# A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

> **NCT07741656** · NA · RECRUITING · sponsor: **Andromeda Surgical** · enrollment: 50 (estimated)

## Conditions studied

- BPH (Benign Prostatic Hyperplasia)
- HoLEP (Holmium Laser Enucleation of Prostate)

## Interventions

- **DEVICE:** Beacon Platform

## Key facts

- **NCT ID:** NCT07741656
- **Lead sponsor:** Andromeda Surgical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741656, "A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07741656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*